AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV CongressPR Newsw
Chesapeake Utilities is executing a high-growth strategy anchored by the Florida City Gas acquisition and sustained customer expansion, with revenue up 18.1% year-over-year in Q1 2026. The company's aggressive capex program (CapEx/OCF averaging 130% over the l...
Price trend, volume and key moving averages
Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $1.05-1.9% vs $1.07 | $202M+1.5% vs $199M |
Q2 2026 May 6, 2026 | $2.47+3.8% vs $2.38 | $353M+3.9% vs $340M |
Q1 2026 Feb 25, 2026 | $1.94+0.0% vs $1.94 | $259M+24.1% vs $209M |
Q4 2025 Nov 6, 2025 | $0.82-8.9% vs $0.90 | $180M-23.6% vs $235M |
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV CongressPR Newsw
Bank of America Corp DE acquired a new stake in Chesapeake Utilities Corporation (NYSE: CPK) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 50,451 shares of the utilities provider's stock, valued at approximately $6,179,000. Bank of America Corp DE
AbbVie Announces European Commission Approval of RINVOQÂ (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisPR
NextEra Energy Resources to acquire a minority interest in landmark South Florida natural gas infrastructure project. DOVER, Del.
Benchmark CPK against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Chesapeake Utilities Corporation (CPK)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $127.38 | $3.06B | 21.34 | 18.14% | 15.09% | 9.39% | 2.03% | |
| $77.54 | $4.58B | 17.74 | -4.5% | 21.62% | 21.39% | — | |
| $51.59 | $5.21B | 15.49 | 13.94% | 16.38% | 14.42% | — | |
| $21.80 | $226.88M | 16.90 | 12.63% | 13.05% | 11.73% | — | |
| $82.69 | $5.98B | 13.60 | -62.05% | 29.83% | 12.89% | — | |
| $72.57 | $4.55B | 16.61 | 16.5% | 12.47% | 8.42% | — |
Chesapeake Utilities Corporation (CPK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Chesapeake Utilities Corporation (CPK) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jul 13, 2026·SEC
May 8, 2026·SEC
Get notified when CPK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Chesapeake Utilities Corporation (CPK) stock FAQ — growth, dividends, profitability & financials explained
Chesapeake Utilities Corporation (CPK) reported $993.6M in revenue for fiscal year 2025. This represents a 733% increase from $119.3M in 1996.
Chesapeake Utilities Corporation (CPK) grew revenue by 18.1% over the past year. This is strong growth.
Yes, Chesapeake Utilities Corporation (CPK) is profitable, generating $150.2M in net income for fiscal year 2025 (15.1% net margin).
Yes, Chesapeake Utilities Corporation (CPK) pays a dividend with a yield of 2.03%. This makes it attractive for income-focused investors.
Chesapeake Utilities Corporation (CPK) has a return on equity (ROE) of 9.4%. This is below average, suggesting room for improvement.
Chesapeake Utilities Corporation (CPK) had negative free cash flow of $281.0M in fiscal year 2025, likely due to heavy capital investments.
Chesapeake Utilities Corporation (CPK) has a dividend payout ratio of 43%. This suggests the dividend is well-covered and sustainable.